290 related articles for article (PubMed ID: 20078957)
1. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of benidipine hydrochloride on severe left ventricular hypertrophy and collagen metabolism in patients with essential hypertension.
Hirono O; Fatema K; Nitobe J; Takeishi Y; Kaneko K; Shiga R; Kubota I
J Cardiol; 2002 Apr; 39(4):195-204. PubMed ID: 11977767
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
[TBL] [Abstract][Full Text] [Related]
5. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
[TBL] [Abstract][Full Text] [Related]
6. [Effects of different Chinese medicine therapeutic methods on the ventricular remodeling and the heart function in chronic heart failure rats of Shen-yang deficiency syndrome].
Wang J; Wu SD; Chen SC
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Sep; 32(9):1238-44. PubMed ID: 23185767
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Tayebjee MH; Nadar SK; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):770-4. PubMed ID: 15363818
[TBL] [Abstract][Full Text] [Related]
8. Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
Hung CS; Chou CH; Wu XM; Chang YY; Wu VC; Chen YH; Chang YS; Tsai YC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
J Hypertens; 2015 Sep; 33(9):1922-30; discussion 1930. PubMed ID: 26103125
[TBL] [Abstract][Full Text] [Related]
9. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
Hansson J; Lind L; Hulthe J; Sundström J
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
[TBL] [Abstract][Full Text] [Related]
10. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
11. [Tei index for right ventricular function monitoring in pregnant women complicated with cardiac disease and pulmonary hypertension].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):341-4. PubMed ID: 19573308
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension.
Ritter AM; de Faria AP; Barbaro N; Sabbatini AR; Corrêa NB; Brunelli V; Amorim R; Modolo R; Moreno H
Blood Press; 2017 Apr; 26(2):122-129. PubMed ID: 27825280
[TBL] [Abstract][Full Text] [Related]
13. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
[TBL] [Abstract][Full Text] [Related]
14. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.
Walther T; Schubert A; Falk V; Binner C; Kanev A; Bleiziffer S; Walther C; Doll N; Autschbach R; Mohr FW
Circulation; 2001 Sep; 104(12 Suppl 1):I54-8. PubMed ID: 11568030
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
Li-Saw-Hee FL; Edmunds E; Blann AD; Beevers DG; Lip GY
Int J Cardiol; 2000 Aug; 75(1):43-7. PubMed ID: 11054505
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
[TBL] [Abstract][Full Text] [Related]
17. [Airway remodeling assessed by high-resolution computed tomography in patients with asthma: relationship to biological markers in induced sputum].
Wu SM; Li CE; Cai RP; Zhang Q; Xu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Dec; 35(12):892-6. PubMed ID: 23328178
[TBL] [Abstract][Full Text] [Related]
18. [Effect of smokers'sera on Porphyromonas gingivalis internalizing KB cells and the expression of matrix metalloproteinase-1, -9 and tissue inhibitor of metalloproteinase-1].
Wang H; Tan L; Liu J; Li Q; Pan Y; Zhong M
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Jan; 49(1):15-20. PubMed ID: 24697882
[TBL] [Abstract][Full Text] [Related]
19. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy.
Schwartzkopff B; Fassbach M; Pelzer B; Brehm M; Strauer BE
Eur J Heart Fail; 2002 Aug; 4(4):439-4. PubMed ID: 12167381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
